SURGE Therapeutics

📍 Cambridge, United States👥 8 employees💰 Last funded Apr 2022
Biotechnology Research🌐 surgetx.com
Website LinkedIn
SURGE seeks to dramatically improve cancer patient survival by disrupting how, when, and where cancer immunotherapy is deployed -- focusing 100% of the effective dose at the right place and at the right time. Surgery is the standard of care for most patients with solid tumors, and we are working tirelessly to ensure that nobody grieves the loss of a loved one to preventable post-surgical cancer recurrence.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in SURGE Therapeutics?
SURGE Therapeutics has 2 investors on record on gritt.io.
When did SURGE Therapeutics last raise funding?
The most recent investment in SURGE Therapeutics recorded on gritt.io was in April 2022.
What industry is SURGE Therapeutics in?
SURGE Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SURGE Therapeutics based?
SURGE Therapeutics is headquartered in Cambridge, United States.